Global Specialty Generics Market Opportunities and Forecast 2020-2027

  • DLR2931
  • 05 January, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Specialty Generics Market, By Type (Injectables, Oral, Others),By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others),By Distribution Channel(Specialty pharmacy, Retail pharmacy, Hospital pharmacy),and opportunities and forecast 2020-2027

Specialty Generics Market Overview

Favourable reimbursement policies, increasing prevalence of cancers, specialty medicine patent expiries, reforms enacted by government bodies, payer’s pressures to reduce the drug drugs, and lack of generic medicine to treat complex diseases are expected to spice up demand for speciality generics throughout the forecast period. according to National Cancer Institute, every year million cases of cancers are newly diagnosed per annum in U.S. and 0.5 million deaths occur due to different type of cancers.

Development of speciality generics is a complex method and needs skilled workforce and sourcing of raw materials. These long challenges will impede the expansion of the market throughout the forecast period.

Development of efficient medicine to treat medical specialty, induration and different infectious diseases will produce vital opportunities for the specialty generics makers. for example, a patient must pay around US$ seventy two,000 annually to treat induration conditions by mistreatment copaxone (Glatiramer). However, Novartis developed generic version of copaxone that prices solely US$ sixty three,000. Hence, several insurance firms are showing interest to reimburse the specialty generics as a result of their low price. supported malady indication, medical specialty and Infectious diseases phase is anticipated to grow with a big CAGR as a result of increasing product patent expirations over the forecast period.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Type, Application, Distribution Channel and Region
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Sumitomo dainippon pharma, Sellas, ISA Pharmaceuticals, Generex Biotechnology, Immatics, Shionogi & Co., Ltd., BrightPath Biotherapeutics, AMAL Therapeutics (AMAL).


The covid-19 Impact on Specialty Generics Market:

Whereas, the chemicals sectors were relatively affected during the pandemic. This is primarily due to uncut demand for chemicals for healthcare, life wisdom, and drawing agents. However, other elements of chemical and material sectors such as types of paints, industrial oil, construction materials are facing reduction in demand. Strict lockdown reflected in a nearly 50-60% reduction in force for raw supply and availability, which directly affected the manufacturing process. Further, halt on numerous end-use diligence directly affected the chemical demand each around the world.
 
Specialty Generics market Segment Overview




By Type, the injectables segment accounted for the largest market share because of many benefits, like fast absorption, long duration of action, and immediate dose distribution. the increase in prevalence of chronic diseases like inflammatory conditions, multiple sclerosis, and cancer is additionally expected to drive the demand for injectables.
 
By Application, Oncology dominated the general market in terms of revenue. accrued incidence of cancer, like breast cancer, prostate cancer, melanoma, colon cancer, lung cancer, and leukaemia, has led to rise in demand for generic specialty medicines across the world. in step with the International Agency for analysis on Cancer (IARC).
By Distribution Channel, specialty pharmacy command the biggest revenue share within the overall market as these specialty medicines are extremely advanced, costly, and want to be handled terribly rigorously. Thus, these medicine are specifically distributed by makers through these pharmacies. a number of the key pharmacies are CVS Health, specific Scripts company, and Diplomat Pharmacy, Inc.
 
Market Analysis, Insights and Forecast – By Type
·       Injectables
·       Oral
·       Others

Market Analysis, Insights and Forecast – By Application
·       Oncology
·       Inflammatory conditions
·       Multiple sclerosis
·       Hepatitis C
·       Others

Market Analysis, Insights and Forecast – By  Distribution Channel
·       Specialty pharmacy
·       Retail pharmacy
·       Hospital pharmacy

Specialty Generics Market Regional Overview

Region-wise, in terms of regions , the global specialty generics market is assessed into regions particularly, North America, Latin America, Western Europe, eastern Europe, Asia-Pacific excluding Japan, Japan, and Near East and Africa. North America expected to dominate the worldwide marketplace for specialty generics because of favorable government policies and increasing specialty generic product launches over the forecast period. large number of generic players and lack of specialty medication within the Asia -Pacific market expected to spice up the expansion of the specialty generics market growth in APEJ region over the forecast period.

Specialty Generics Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Specialty Generics Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Specialty Genericsare highlighted below.

·       In 2015, Teva Pharmaceutical Ltd. acquired Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa) that concerned in development specialty generic products, to reinforce their sales in specialty generics market.

Specialty Generics Market, Key Players -

·       Valeant Pharmaceuticals International, Inc.,
·       Novartis,
·       Pfizer Inc.,
·       Turing Pharmaceuticals,
·       Teva Pharmaceutical Ltd.,
·       Mylan N.V.,
·       Akorn, Inc.,
·       Mallinckrodt
 

Frequently Asked Questions (FAQ) :

Q1. What is the total CAGR expected to be recorded for the Specialty Generics Market during the forecast period?

A. Specialty Generics market is expected to record a CAGR of ~ XX % during the forecast period.

Q2. Which segment is projected to hold the largest share in the Specialty Generics Market?

A. Injectables segment is projected to hold the largest share in the Specialty Generics Market.

Q3. What are the driving factors for the Specialty Generics Market?

A. Favorable reimbursement policies, increasing prevalence of cancers, specialty medicine patent expires, reforms enacted by government bodies, payer’s pressures to reduce the drug drugs, these are main factors driving the growth of automotive lighting market.

Q4. Which Segments are covered in the Specialty Generics Market report?

A. Type , Application, Distribution Channel and Region, these segments are covered in the Specialty Generics Market report.

Q5. Which are the prominent players offering Specialty Generics Market?

A. Valeant Pharmaceuticals International, Inc., Novartis, Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd., Mylan N.V.,Akorn, Inc., and Mallinckrodt.
Specialty Generics Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. GlobalSpecialty GenericsMarket analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Type
        • 5.2.1. Injectables
        • 5.2.2. Oral
        • 5.2.3. Others
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Oncology
        • 5.3.2. Inflammatory conditions
        • 5.3.3. Multiple sclerosis
        • 5.3.4. Hepatitis C
        • 5.3.5. Others
      • 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 5.4.1. Specialty pharmacy
        • 5.4.2. Retail pharmacy
        • 5.4.3. Hospital pharmacy
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East, and Africa

      6. North America Specialty Generics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Type
        • 6.2.1. Injectables
        • 6.2.2. Oral
        • 6.2.3. Others
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Oncology
        • 6.3.2. Inflammatory conditions
        • 6.3.3. Multiple sclerosis
        • 6.3.4. Hepatitis C
        • 6.3.5. Others
      • 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 6.4.1. Specialty pharmacy
        • 6.4.2. Retail pharmacy
        • 6.4.3. Hospital pharmacy
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. UK
        • 6.5.2. Germany
        • 6.5.3. France
        • 6.5.4. Italy
        • 6.5.5. Spain
        • 6.5.6. Russia
        • 6.5.7. Rest of Europe

      7. Asia Pacific Specialty Generics Market Analysis(USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Type
        • 7.2.1. Injectables
        • 7.2.2. Oral
        • 7.2.3. Others
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Oncology
        • 7.3.2. Inflammatory conditions
        • 7.3.3. Multiple sclerosis
        • 7.3.4. Hepatitis C
        • 7.3.5. Others
      • 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 7.4.1. Specialty pharmacy
        • 7.4.2. Retail pharmacy
        • 7.4.3. Hospital pharmacy
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. China
        • 7.5.2. India
        • 7.5.3. Japan
        • 7.5.4. Australia
        • 7.5.5. South East Asia
        • 7.5.6. Rest of Asia Pacific

      8. Latin America, Middle East, and Africa Specialty Generics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Type
        • 8.2.1. Injectables
        • 8.2.2. Oral
        • 8.2.3. Others
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Oncology
        • 8.3.2. Inflammatory conditions
        • 8.3.3. Multiple sclerosis
        • 8.3.4. Hepatitis C
        • 8.3.5. Others
      • 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 8.4.1. Specialty pharmacy
        • 8.4.2. Retail pharmacy
        • 8.4.3. Hospital pharmacy
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. Brazil
        • 8.5.2. Saudi Arabia
        • 8.5.3. UAE
        • 8.5.4. Rest of LAMEA

      9. Competitive Analysis

      • 9.1. Company Market Share Analysis, 2018
      • 9.2. Key Industry Developments
      • 9.3. Company Profile
      • 9.4. Valeant Pharmaceuticals International, Inc.,
        • 9.4.1. Business Overview
        • 9.4.2. Segment 1 & Service Offering
        • 9.4.3. Overall Revenue
        • 9.4.4. Geographic Presence
        • 9.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 9.5. Novartis,
      • 9.6. Pfizer Inc.,
      • 9.7. Turing Pharmaceuticals,
      • 9.8. Teva Pharmaceutical Ltd.,
      • 9.9. Mylan N.V.,
      • 9.10. Akorn, Inc.,

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934